St. Paul's Advanced Resection Center Cohort for Colorectal Neoplasia (SPARC-C)
Launched by UNIVERSITY OF BRITISH COLUMBIA · May 28, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The SPARC-C study is looking at how to manage large non-pedunculated colorectal polyps, which are abnormal growths in the colon that are at least 20mm in size. This research is being conducted at a single center and aims to collect information on patients' health, the details of their polyps, the procedures used to treat them, and the outcomes after treatment. By gathering this data, the study hopes to improve the care provided to patients with these types of polyps.
To participate in this trial, you need to be at least 18 years old and referred for treatment of a large polyp. You should also be able to give your consent to join the study. Unfortunately, if you are pregnant or breastfeeding, you won't be eligible. If you join the study, you can expect to receive standard care for your condition, and your experiences will be documented to help enhance future treatment strategies. This study is currently recruiting participants, and everyone, regardless of gender, is welcome to apply.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients ≥ 18 years of age referred for the management of an LNPCP
- • Able to provide informed consent.
- Exclusion Criteria:
- • Unable to provide informed consent
- • Pregnant or lactating women.
About University Of British Columbia
The University of British Columbia (UBC) is a leading research institution located in Vancouver, Canada, renowned for its commitment to advancing health sciences through innovative research and education. As a prominent clinical trial sponsor, UBC leverages its interdisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies aimed at improving patient outcomes across various medical fields. The university fosters collaborations with healthcare professionals, industry partners, and community stakeholders to translate research findings into practical applications, thereby contributing to the global advancement of medicine and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Vancouver, British Columbia, Canada
Vancouver, British Columbia, Canada
Vancouver, British Columbia, Canada
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials